HEADER TRANSFERASE 28-FEB-20 6Y7F TITLE CRYSTAL STRUCTURE OF HUMAN ELOVL FATTY ACID ELONGASE 7 (ELOVL7) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3-KETO ACYL-COA SYNTHASE ELOVL7,ELOVL FATTY ACID ELONGASE 7, COMPND 5 ELOVL FA ELONGASE 7,VERY LONG CHAIN 3-KETOACYL-COA SYNTHASE 7,VERY COMPND 6 LONG CHAIN 3-OXOACYL-COA SYNTHASE 7; COMPND 7 EC: 2.3.1.199; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOVL7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFB-CT10HF-LIC KEYWDS FATTY ACID BIOSYNTHESIS, LIPID BIOSYNTHESIS, MEMBRANE PROTEIN, KEYWDS 2 STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.NIE,A.C.W.PIKE,S.R.BUSHELL,A.CHU,V.COLE,D.SPEEDMAN,K.E.J.RODSTROM, AUTHOR 2 K.KUPINSKA,L.SHRESTHA,S.M.M.MUKHOPADHYAY,N.A.BURGESS-BROWN,J.LOVE, AUTHOR 3 A.M.EDWARDS,C.H.ARROWSMITH,C.BOUNTRA,E.P.CARPENTER,STRUCTURAL AUTHOR 4 GENOMICS CONSORTIUM (SGC) REVDAT 1 13-MAY-20 6Y7F 0 JRNL AUTH L.NIE,A.C.W.PIKE,S.R.BUSHELL,A.CHU,V.COLE,D.SPEEDMAN, JRNL AUTH 2 K.KUPINSKA,L.SHRESTHA,S.M.M.MUKHOPADHYAY,N.A.BURGESS-BROWN, JRNL AUTH 3 J.LOVE,A.M.EDWARDS,C.H.ARROWSMITH,C.BOUNTRA,E.P.CARPENTER JRNL TITL CRYSTAL STRUCTURE OF HUMAN ELOVL FATTY ACID ELONGASE 7 JRNL TITL 2 (ELOVL7) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 58.7 REMARK 3 NUMBER OF REFLECTIONS : 36690 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1765 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 15.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1967 REMARK 3 BIN FREE R VALUE : 0.1817 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 29 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4245 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 293 REMARK 3 SOLVENT ATOMS : 112 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 18.37970 REMARK 3 B22 (A**2) : -10.86810 REMARK 3 B33 (A**2) : -7.51150 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.86870 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.251 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.191 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.261 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.197 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.889 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.876 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4733 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6461 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2117 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 743 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4733 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 597 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3786 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.07 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.97 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|16 - 301} REMARK 3 ORIGIN FOR THE GROUP (A): 18.4534 36.4171 16.2398 REMARK 3 T TENSOR REMARK 3 T11: -0.0551 T22: -0.3474 REMARK 3 T33: -0.3082 T12: -0.0232 REMARK 3 T13: -0.0421 T23: -0.0327 REMARK 3 L TENSOR REMARK 3 L11: 1.176 L22: 2.7466 REMARK 3 L33: 3.5473 L12: 0.1033 REMARK 3 L13: 0.2759 L23: -0.5722 REMARK 3 S TENSOR REMARK 3 S11: 0.0605 S12: 0.0678 S13: 0.0496 REMARK 3 S21: 0.0678 S22: -0.0353 S23: 0.3528 REMARK 3 S31: 0.0496 S32: 0.3528 S33: -0.0252 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|14 - 301} REMARK 3 ORIGIN FOR THE GROUP (A): 11.498 66.4697 34.366 REMARK 3 T TENSOR REMARK 3 T11: 0.1117 T22: -0.3438 REMARK 3 T33: -0.3207 T12: 0.0433 REMARK 3 T13: -0.0494 T23: -0.0676 REMARK 3 L TENSOR REMARK 3 L11: 1.4333 L22: 3.8033 REMARK 3 L33: 3.1779 L12: 0.0358 REMARK 3 L13: 0.4332 L23: -0.6925 REMARK 3 S TENSOR REMARK 3 S11: -0.1311 S12: 0.7265 S13: -0.0845 REMARK 3 S21: 0.7265 S22: 0.0203 S23: -0.0766 REMARK 3 S31: -0.0845 S32: -0.0766 S33: 0.1109 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE REFINED AGAINST STARANISO REMARK 3 ANISOTROPICALLY TRUNCATED DATA. LSSR RESTRAINTS WERE USED AND A REMARK 3 SINGLE TLS GROUP WAS REFINED FOR EACH CHAIN. HETEROGEN REMARK 3 DICTIONARIES WERE GENERATED USING GRADE. ACCOMPANYING SF CIF REMARK 3 CONTAINS STARANISO DATA USED FOR REFINEMENT ALONG WITH SCALED REMARK 3 MERGED DATA WITHOUT TRUNCATION. REMARK 4 REMARK 4 6Y7F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 2.0.3 REMARK 200 DATA SCALING SOFTWARE : STARANISO 2.3.25 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36724 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.052 REMARK 200 RESOLUTION RANGE LOW (A) : 62.262 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 58.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 17.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.70300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: AUTOSOL 1.17.1-3660, RESOLVE 1.17.1-3660 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-36% PEG400 -- 0.1M ACETATE PH 4.5 - REMARK 280 - 0.23M SODIUM CHLORIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.22950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PHE A 3 REMARK 465 SER A 4 REMARK 465 ASP A 5 REMARK 465 LEU A 6 REMARK 465 THR A 7 REMARK 465 SER A 8 REMARK 465 ARG A 9 REMARK 465 THR A 10 REMARK 465 VAL A 11 REMARK 465 HIS A 12 REMARK 465 LEU A 13 REMARK 465 TYR A 14 REMARK 465 ASP A 15 REMARK 465 THR A 270 REMARK 465 VAL A 271 REMARK 465 LYS A 272 REMARK 465 ASN A 273 REMARK 465 GLY A 274 REMARK 465 THR A 275 REMARK 465 CYS A 276 REMARK 465 LYS A 277 REMARK 465 ASN A 278 REMARK 465 LYS A 279 REMARK 465 ASP A 280 REMARK 465 ASN A 281 REMARK 465 ALA A 282 REMARK 465 GLU A 283 REMARK 465 ASN A 284 REMARK 465 LEU A 285 REMARK 465 TYR A 286 REMARK 465 PHE A 287 REMARK 465 GLN A 288 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 PHE B 3 REMARK 465 SER B 4 REMARK 465 ASP B 5 REMARK 465 LEU B 6 REMARK 465 THR B 7 REMARK 465 SER B 8 REMARK 465 ARG B 9 REMARK 465 THR B 10 REMARK 465 VAL B 11 REMARK 465 HIS B 12 REMARK 465 LEU B 13 REMARK 465 THR B 270 REMARK 465 VAL B 271 REMARK 465 LYS B 272 REMARK 465 ASN B 273 REMARK 465 GLY B 274 REMARK 465 THR B 275 REMARK 465 CYS B 276 REMARK 465 LYS B 277 REMARK 465 ASN B 278 REMARK 465 LYS B 279 REMARK 465 ASP B 280 REMARK 465 ASN B 281 REMARK 465 ALA B 282 REMARK 465 GLU B 283 REMARK 465 ASN B 284 REMARK 465 LEU B 285 REMARK 465 TYR B 286 REMARK 465 PHE B 287 REMARK 465 GLN B 288 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 16 CG OD1 ND2 REMARK 470 ILE A 18 CG1 CG2 CD1 REMARK 470 LYS A 19 CG CD CE NZ REMARK 470 GLU A 26 CG CD OE1 OE2 REMARK 470 LYS A 54 CG CD CE NZ REMARK 470 GLU A 57 CG CD OE1 OE2 REMARK 470 LYS A 66 CD CE NZ REMARK 470 ARG A 98 CZ NH1 NH2 REMARK 470 LYS A 199 CG CD CE NZ REMARK 470 LYS A 232 CE NZ REMARK 470 ASP B 15 CG OD1 OD2 REMARK 470 LYS B 19 CD CE NZ REMARK 470 LYS B 54 CD CE NZ REMARK 470 GLU B 57 CD OE1 OE2 REMARK 470 LYS B 60 CD CE NZ REMARK 470 GLU B 63 CD OE1 OE2 REMARK 470 LYS B 66 CD CE NZ REMARK 470 TYR B 197 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 199 CG CD CE NZ REMARK 470 ASP B 230 CG OD1 OD2 REMARK 470 LYS B 232 CE NZ REMARK 470 LYS B 269 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 50 -68.04 -128.83 REMARK 500 ARG A 98 -110.10 -126.58 REMARK 500 ARG A 106 35.06 -97.05 REMARK 500 LEU A 201 52.26 -93.14 REMARK 500 SER B 50 -68.07 -128.76 REMARK 500 ARG B 98 -110.45 -126.63 REMARK 500 ARG B 106 34.48 -97.97 REMARK 500 LEU B 201 51.20 -93.41 REMARK 500 ARG B 266 53.27 -140.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 37X A 304 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OFN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37X A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37X A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37X A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 37X B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OFN B 301 and HIS B REMARK 800 181 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OFN B 301 and HIS B REMARK 800 150 DBREF 6Y7F A 1 281 UNP A1L3X0 ELOV7_HUMAN 1 281 DBREF 6Y7F B 1 281 UNP A1L3X0 ELOV7_HUMAN 1 281 SEQADV 6Y7F ALA A 282 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F GLU A 283 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F ASN A 284 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F LEU A 285 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F TYR A 286 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F PHE A 287 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F GLN A 288 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F ALA B 282 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F GLU B 283 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F ASN B 284 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F LEU B 285 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F TYR B 286 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F PHE B 287 UNP A1L3X0 EXPRESSION TAG SEQADV 6Y7F GLN B 288 UNP A1L3X0 EXPRESSION TAG SEQRES 1 A 288 MET ALA PHE SER ASP LEU THR SER ARG THR VAL HIS LEU SEQRES 2 A 288 TYR ASP ASN TRP ILE LYS ASP ALA ASP PRO ARG VAL GLU SEQRES 3 A 288 ASP TRP LEU LEU MET SER SER PRO LEU PRO GLN THR ILE SEQRES 4 A 288 LEU LEU GLY PHE TYR VAL TYR PHE VAL THR SER LEU GLY SEQRES 5 A 288 PRO LYS LEU MET GLU ASN ARG LYS PRO PHE GLU LEU LYS SEQRES 6 A 288 LYS ALA MET ILE THR TYR ASN PHE PHE ILE VAL LEU PHE SEQRES 7 A 288 SER VAL TYR MET CYS TYR GLU PHE VAL MET SER GLY TRP SEQRES 8 A 288 GLY ILE GLY TYR SER PHE ARG CYS ASP ILE VAL ASP TYR SEQRES 9 A 288 SER ARG SER PRO THR ALA LEU ARG MET ALA ARG THR CYS SEQRES 10 A 288 TRP LEU TYR TYR PHE SER LYS PHE ILE GLU LEU LEU ASP SEQRES 11 A 288 THR ILE PHE PHE VAL LEU ARG LYS LYS ASN SER GLN VAL SEQRES 12 A 288 THR PHE LEU HIS VAL PHE HIS HIS THR ILE MET PRO TRP SEQRES 13 A 288 THR TRP TRP PHE GLY VAL LYS PHE ALA ALA GLY GLY LEU SEQRES 14 A 288 GLY THR PHE HIS ALA LEU LEU ASN THR ALA VAL HIS VAL SEQRES 15 A 288 VAL MET TYR SER TYR TYR GLY LEU SER ALA LEU GLY PRO SEQRES 16 A 288 ALA TYR GLN LYS TYR LEU TRP TRP LYS LYS TYR LEU THR SEQRES 17 A 288 SER LEU GLN LEU VAL GLN PHE VAL ILE VAL ALA ILE HIS SEQRES 18 A 288 ILE SER GLN PHE PHE PHE MET GLU ASP CYS LYS TYR GLN SEQRES 19 A 288 PHE PRO VAL PHE ALA CYS ILE ILE MET SER TYR SER PHE SEQRES 20 A 288 MET PHE LEU LEU LEU PHE LEU HIS PHE TRP TYR ARG ALA SEQRES 21 A 288 TYR THR LYS GLY GLN ARG LEU PRO LYS THR VAL LYS ASN SEQRES 22 A 288 GLY THR CYS LYS ASN LYS ASP ASN ALA GLU ASN LEU TYR SEQRES 23 A 288 PHE GLN SEQRES 1 B 288 MET ALA PHE SER ASP LEU THR SER ARG THR VAL HIS LEU SEQRES 2 B 288 TYR ASP ASN TRP ILE LYS ASP ALA ASP PRO ARG VAL GLU SEQRES 3 B 288 ASP TRP LEU LEU MET SER SER PRO LEU PRO GLN THR ILE SEQRES 4 B 288 LEU LEU GLY PHE TYR VAL TYR PHE VAL THR SER LEU GLY SEQRES 5 B 288 PRO LYS LEU MET GLU ASN ARG LYS PRO PHE GLU LEU LYS SEQRES 6 B 288 LYS ALA MET ILE THR TYR ASN PHE PHE ILE VAL LEU PHE SEQRES 7 B 288 SER VAL TYR MET CYS TYR GLU PHE VAL MET SER GLY TRP SEQRES 8 B 288 GLY ILE GLY TYR SER PHE ARG CYS ASP ILE VAL ASP TYR SEQRES 9 B 288 SER ARG SER PRO THR ALA LEU ARG MET ALA ARG THR CYS SEQRES 10 B 288 TRP LEU TYR TYR PHE SER LYS PHE ILE GLU LEU LEU ASP SEQRES 11 B 288 THR ILE PHE PHE VAL LEU ARG LYS LYS ASN SER GLN VAL SEQRES 12 B 288 THR PHE LEU HIS VAL PHE HIS HIS THR ILE MET PRO TRP SEQRES 13 B 288 THR TRP TRP PHE GLY VAL LYS PHE ALA ALA GLY GLY LEU SEQRES 14 B 288 GLY THR PHE HIS ALA LEU LEU ASN THR ALA VAL HIS VAL SEQRES 15 B 288 VAL MET TYR SER TYR TYR GLY LEU SER ALA LEU GLY PRO SEQRES 16 B 288 ALA TYR GLN LYS TYR LEU TRP TRP LYS LYS TYR LEU THR SEQRES 17 B 288 SER LEU GLN LEU VAL GLN PHE VAL ILE VAL ALA ILE HIS SEQRES 18 B 288 ILE SER GLN PHE PHE PHE MET GLU ASP CYS LYS TYR GLN SEQRES 19 B 288 PHE PRO VAL PHE ALA CYS ILE ILE MET SER TYR SER PHE SEQRES 20 B 288 MET PHE LEU LEU LEU PHE LEU HIS PHE TRP TYR ARG ALA SEQRES 21 B 288 TYR THR LYS GLY GLN ARG LEU PRO LYS THR VAL LYS ASN SEQRES 22 B 288 GLY THR CYS LYS ASN LYS ASP ASN ALA GLU ASN LEU TYR SEQRES 23 B 288 PHE GLN HET OFN A 301 70 HET 37X A 302 39 HET 37X A 303 39 HET 37X A 304 34 HET CL A 305 1 HET OFN B 301 70 HET 37X B 302 39 HET CL B 303 1 HETNAM OFN ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5- HETNAM 2 OFN (6-AMINOPURIN-9-YL)-4-OXIDANYL-3-PHOSPHONOOXY-OXOLAN- HETNAM 3 OFN 2-YL]METHOXY-OXIDANYL-PHOSPHORYL]OXY-OXIDANYL- HETNAM 4 OFN PHOSPHORYL]OXY-3,3-DIMETHYL-2-OXIDANYL- HETNAM 5 OFN BUTANOYL]AMINO]PROPANOYLAMINO]ETHYL] 3- HETNAM 6 OFN OXIDANYLIDENEICOSANETHIOATE HETNAM 37X OCTYL GLUCOSE NEOPENTYL GLYCOL HETNAM CL CHLORIDE ION FORMUL 3 OFN 2(C41 H72 N7 O18 P3 S) FORMUL 4 37X 4(C27 H52 O12) FORMUL 7 CL 2(CL 1-) FORMUL 11 HOH *112(H2 O) HELIX 1 AA1 ASN A 16 ALA A 21 5 6 HELIX 2 AA2 ASP A 22 GLU A 26 5 5 HELIX 3 AA3 PRO A 34 SER A 50 1 17 HELIX 4 AA4 SER A 50 GLU A 57 1 8 HELIX 5 AA5 LEU A 64 SER A 89 1 26 HELIX 6 AA6 SER A 107 GLU A 127 1 21 HELIX 7 AA7 LEU A 128 ARG A 137 1 10 HELIX 8 AA8 LYS A 139 VAL A 143 5 5 HELIX 9 AA9 THR A 144 ALA A 165 1 22 HELIX 10 AB1 GLY A 167 GLY A 170 5 4 HELIX 11 AB2 THR A 171 LEU A 193 1 23 HELIX 12 AB3 GLY A 194 LYS A 199 1 6 HELIX 13 AB4 TRP A 203 MET A 228 1 26 HELIX 14 AB5 PRO A 236 TYR A 261 1 26 HELIX 15 AB6 ASN B 16 ALA B 21 5 6 HELIX 16 AB7 ASP B 22 GLU B 26 5 5 HELIX 17 AB8 PRO B 34 SER B 50 1 17 HELIX 18 AB9 SER B 50 GLU B 57 1 8 HELIX 19 AC1 LEU B 64 SER B 89 1 26 HELIX 20 AC2 SER B 107 GLU B 127 1 21 HELIX 21 AC3 LEU B 128 ARG B 137 1 10 HELIX 22 AC4 LYS B 139 VAL B 143 5 5 HELIX 23 AC5 THR B 144 ALA B 165 1 22 HELIX 24 AC6 GLY B 167 GLY B 170 5 4 HELIX 25 AC7 THR B 171 LEU B 193 1 23 HELIX 26 AC8 GLY B 194 LYS B 199 1 6 HELIX 27 AC9 TRP B 203 MET B 228 1 26 HELIX 28 AD1 PRO B 236 TYR B 261 1 26 SSBOND 1 CYS A 99 CYS A 231 1555 1555 2.07 SSBOND 2 CYS B 99 CYS B 231 1555 1555 2.08 LINK NE2 HIS A 150 C25 OFN A 301 1555 1555 1.48 LINK NE2 HIS A 181 C OFN A 301 1555 1555 1.51 LINK NE2 HIS B 150 C25 OFN B 301 1555 1555 1.48 LINK NE2 HIS B 181 C OFN B 301 1555 1555 1.52 SITE 1 AC1 36 MET A 68 TYR A 71 ASN A 72 LYS A 124 SITE 2 AC1 36 ASP A 130 PHE A 133 PHE A 134 ARG A 137 SITE 3 AC1 36 LYS A 139 GLN A 142 HIS A 147 HIS A 150 SITE 4 AC1 36 TRP A 158 GLY A 161 ASN A 177 HIS A 181 SITE 5 AC1 36 MET A 184 TYR A 187 TYR A 188 SER A 191 SITE 6 AC1 36 GLN A 198 LYS A 204 LEU A 207 THR A 208 SITE 7 AC1 36 GLN A 211 PHE A 215 TYR A 245 PHE A 253 SITE 8 AC1 36 PHE A 256 ARG A 266 HOH A 407 HOH A 410 SITE 9 AC1 36 HOH A 414 HOH A 424 HOH A 429 HOH A 440 SITE 1 AC2 6 TYR A 197 TYR A 200 37X A 303 HOH A 409 SITE 2 AC2 6 HOH A 417 HOH A 433 SITE 1 AC3 3 LEU A 190 37X A 302 37X A 304 SITE 1 AC4 5 TYR A 200 TRP A 202 TRP A 203 TYR A 206 SITE 2 AC4 5 37X A 303 SITE 1 AC5 1 ARG A 259 SITE 1 AC6 6 TYR A 81 LEU A 119 PRO B 23 GLU B 26 SITE 2 AC6 6 ARG B 106 HOH B 418 SITE 1 AC7 2 ARG B 259 HOH B 423 SITE 1 AC8 41 MET B 68 TYR B 71 ASN B 72 LYS B 124 SITE 2 AC8 41 GLU B 127 ASP B 130 PHE B 133 PHE B 134 SITE 3 AC8 41 ARG B 137 LYS B 139 GLN B 142 HIS B 147 SITE 4 AC8 41 HIS B 150 GLY B 161 ASN B 177 THR B 178 SITE 5 AC8 41 ALA B 179 VAL B 180 VAL B 182 VAL B 183 SITE 6 AC8 41 MET B 184 TYR B 185 TYR B 187 TYR B 188 SITE 7 AC8 41 SER B 191 ALA B 192 GLN B 198 LYS B 204 SITE 8 AC8 41 LEU B 207 THR B 208 GLN B 211 PHE B 215 SITE 9 AC8 41 TYR B 245 PHE B 253 PHE B 256 ARG B 266 SITE 10 AC8 41 HOH B 406 HOH B 407 HOH B 417 HOH B 426 SITE 11 AC8 41 HOH B 433 SITE 1 AC9 42 MET B 68 TYR B 71 ASN B 72 LYS B 124 SITE 2 AC9 42 ASP B 130 PHE B 133 PHE B 134 ARG B 137 SITE 3 AC9 42 LYS B 139 GLN B 142 LEU B 146 HIS B 147 SITE 4 AC9 42 VAL B 148 PHE B 149 HIS B 151 THR B 152 SITE 5 AC9 42 ILE B 153 MET B 154 GLY B 161 ASN B 177 SITE 6 AC9 42 HIS B 181 MET B 184 TYR B 187 TYR B 188 SITE 7 AC9 42 SER B 191 ALA B 192 GLN B 198 LYS B 204 SITE 8 AC9 42 LEU B 207 THR B 208 GLN B 211 PHE B 215 SITE 9 AC9 42 TYR B 245 PHE B 249 PHE B 253 PHE B 256 SITE 10 AC9 42 ARG B 266 HOH B 406 HOH B 407 HOH B 417 SITE 11 AC9 42 HOH B 426 HOH B 433 CRYST1 63.229 72.459 112.043 90.00 100.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015816 0.000000 0.002797 0.00000 SCALE2 0.000000 0.013801 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009064 0.00000